- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.09. | Fired CDC director says RFK Jr. aims to change childhood vaccine schedule | ||
| 17.09. | Roivant pill succeeds in rare inflammatory disease trial | ||
| 17.09. | GSK ups US investment with $30B spending plan | ||
| 17.09. | Lilly, Novo showcase new obesity drug data; Fasenra falls short in COPD | ||
| 17.09. | Ollin debuts with $100M and plans to challenge top-selling eye drugs | ||
| 16.09. | CSL nabs option to acquire a startup and its blood-clotting drug | ||
| 16.09. | Former CinCor execs reunite to helm new biotech startup | ||
| 15.09. | ATyr shares plunge on trial miss in inflammatory lung disease | ||
| 15.09. | A key CDC panel meets this week to discuss vaccines. Here's what to know. | ||
| 15.09. | Novartis dives deeper into protein degraders with second Monte Rosa deal | ||
| 15.09. | Working smarter: best practices for thermal modeling in cold chain packaging design | ||
| 15.09. | Reaching more patients: How AI and data drive better representation in clinical trials | ||
| 12.09. | Takeda poaches top Lilly exec; Maze soars on early PKU drug data | ||
| 12.09. | Ozempic for cancer? Signs point to potential benefits of GLP-1s in oncology | ||
| 11.09. | Prasad regains role as FDA's top doctor, scientist | ||
| 11.09. | Child dies in Capsida study of rare disease gene therapy | ||
| 11.09. | FDA shares guidance to drugmakers developing non-opioid pain medicines | ||
| 10.09. | FDA clears J&J's drug-device combo for bladder cancer | ||
| 10.09. | Kriya, Odyssey secure 'megarounds'; Amgen boosts R&D leadership | ||
| 10.09. | Novo Nordisk to lay off 9,000 workers in major restructuring | ||
| 10.09. | [Podcast] The Progress Profile: Alzheimer's Research in Focus | ||
| 09.09. | Lilly to give biotech startups access to AI tools | ||
| 09.09. | Novartis to gain heart drug in $1.4B deal for Tourmaline Bio | ||
| 09.09. | BioNTech says dual-acting lung cancer drug helped shrink tumors | ||
| 08.09. | A new class of sleep drugs draws Wall Street's attention |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .